In this regard, Li et al. observed that miR-548a-3p can diminish SIX1 expression through directly targeting its 3′-UTR, which leads to a notable decrease in the expression of GLUT1 in breast cancer. The gene discussed is SLC2A1; the disease is breast carcinoma.